Sfoglia per Autore
Rationale of the Inclusion of β-Blockers Among Major Antihypertensive Drugs in the 2023 European Society of Hypertension Guidelines
2024 Mancia, G; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Kjeldsen, S; Muiesan, M; Thomopoulos, C; Tsioufis, K; Kreutz, R
Cardio-Ankle Vascular Index As A Marker Of Left Ventricular Hypertrophy In Treated Hypertensives: Findings From The Pamela Study
2024 Cuspidi, C; Facchetti, R; Quarti-Trevano, F; Dell'Oro, R; Mancia, G; Grassi, G
The diagnostic approach and management of hypertension in the emergency department
2024 Manolis, A; Kallistratos, M; Koutsaki, M; Doumas, M; Poulimenos, L; Parissis, J; Polyzogopoulou, E; Pittaras, A; Muiesan, M; Mancia, G
Assessment and management of exaggerated blood pressure response to standing and orthostatic hypertension: consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability
2024 Palatini, P; Kollias, A; Saladini, F; Asmar, R; Bilo, G; Kyriakoulis, K; Parati, G; Stergiou, G; Grassi, G; Kreutz, R; Mancia, G; Jordan, J; Biaggioni, I; de la Sierra, A
Randomized Clinical Outcome Trials in Hypertension
2024 Mancia, G; Kjeldsen, S
Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients
2024 Mancia, G; Facchetti, R; Quarti-Trevano, F; Dell'Oro, R; Cuspidi, C; Grassi, G
Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern
2024 Kreutz, R; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Kjeldsen, S; Muiesan, M; Thomopoulos, C; Tsioufis, K; Mancia, G
Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study
2024 Quarti Trevano, F; Bernal, S; Facchetti, R; Cuspidi, C; Mancia, G; Grassi, G
Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?
2024 Kreutz, R; Palatini, P; Stergiou, G; Mancia, G
The 2023 European Society of Hypertension guidelines for high blood pressure – What's new on diagnostic and therapeutic approaches
2024 Grassi, G; Kreutz, R; Mancia, G
Why were the 2023 Guidelines of the European Society of Hypertension not developed as Joint Guidelines together with the European Society of Cardiology?
2024 Kreutz, R; Azizi, M; Grassi, G; Januszewicz, A; Kahan, T; Lurbe, E; Polonia, J; Tsioufis, K; Weber, T; Williams, B; Mancia, G
New European Guidelines 2023 for Hypertension: When and Why Should We Think About Sleep Apnea?
2024 Grassi, G; Mancia, G
Long-term increase in serum uric acid and its predictors over a 25 year follow-up: Results of the PAMELA study
2024 Maloberti, A; Dell'Oro, R; Bombelli, M; Quarti-Trevano, F; Facchetti, R; Mancia, G; Grassi, G
Risk of Dementia During Antihypertensive Drug Therapy in the Elderly
2024 Rea, F; Corrao, G; Mancia, G
The current best drug treatment for hypertensive heart failure with preserved ejection fraction
2024 Rist, A; Sevre, K; Wachtell, K; Devereux, R; Aurigemma, G; Smiseth, O; Kjeldsen, S; Julius, S; Pitt, B; Burnier, M; Kreutz, R; Oparil, S; Mancia, G; Zannad, F
Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
2024 Mancia, G; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Muiesan, M; Tsioufis, K; Kjeldsen, S; Kreutz, R
HYPERTENSION IN CANCER PATIENTS TREATED WITH ANTI-ANGIOGENIC BASED THERAPY: A POPULATION-BASED COHORT STUDY
2023 Franchi, M; Torrigiani, G; Corrao, G; Mancia, G
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA)
2023 Mancia, G; Kreutz, R; Brunström, M; Burnier, M; Grassi, G; Januszewicz, A; Muiesan, M; Tsioufis, K; Agabiti-Rosei, E; Algharably, E; Azizi, M; Benetos, A; Borghi, C; Hitij, J; Cifkova, R; Coca, A; Cornelissen, V; Cruickshank, J; Cunha, P; Danser, A; Pinho, R; Delles, C; Dominiczak, A; Dorobantu, M; Doumas, M; Fernández-Alfonso, M; Halimi, J; Járai, Z; Jelaković, B; Jordan, J; Kuznetsova, T; Laurent, S; Lovic, D; Lurbe, E; Mahfoud, F; Manolis, A; Miglinas, M; Narkiewicz, K; Niiranen, T; Palatini, P; Parati, G; Pathak, A; Persu, A; Polonia, J; Redon, J; Sarafidis, P; Schmieder, R; Spronck, B; Stabouli, S; Stergiou, G; Taddei, S; Thomopoulos, C; Tomaszewski, M; Van de Borne, P; Wanner, C; Weber, T; Williams, B; Zhang, Z; Kjeldsen, S
REAL-WORLD ANALYSIS OF ADHERENCE, OUTCOMES AND HEALTHCARE COSTS OF THE QUADRUPLE COMBINATION PERINDOPRIL, INDAPAMIDE, AMLODIPINE AND BISOPROLOL IN ITALY
2023 Mancia, G; Brouwers, S; Desideri, G; Esposti, L; Perrone, V; Narkiewicz, K
THE IMPACT OF RENAL DENERVATION PROCEDURE ON THE USE OF ANTIHYPERTENSIVE DRUGS. A REAL-LIFE INVESTIGATION FROM ITALY
2023 Rea, F; Morabito, G; Savare, L; Corrao, G; Mancia, G
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile